• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Novel Small Molecule-Derived, Highly Selective Substrates for Fibroblast Activation Protein (FAP).新型小分子衍生的成纤维细胞活化蛋白(FAP)高选择性底物
ACS Med Chem Lett. 2019 Jul 9;10(8):1173-1179. doi: 10.1021/acsmedchemlett.9b00191. eCollection 2019 Aug 8.
2
and Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes.以及用UAMC1110衍生探针进行的基于活性的成纤维细胞活化蛋白标记。
Front Chem. 2021 Apr 14;9:640566. doi: 10.3389/fchem.2021.640566. eCollection 2021.
3
Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA chelators.靶向成纤维细胞活化蛋白(FAP):使用方酸酰胺偶联双功能DOTA和DATA螯合剂的新一代PET放射性示踪剂
EJNMMI Radiopharm Chem. 2020 Jul 29;5(1):19. doi: 10.1186/s41181-020-00102-z.
4
Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity.酰化甘氨酰-(2-氰基)吡咯烷类作为成纤维细胞激活蛋白 (FAP) 的抑制剂及 FAP/脯氨酰寡肽酶 (PREP) 选择性的问题。
Bioorg Med Chem Lett. 2012 May 15;22(10):3412-7. doi: 10.1016/j.bmcl.2012.03.107. Epub 2012 Apr 4.
5
Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs.定量检测小鼠、狒狒和人体液及器官中成纤维细胞激活蛋白(FAP)特异性蛋白酶活性。
FEBS Open Bio. 2013 Dec 8;4:43-54. doi: 10.1016/j.fob.2013.12.001. eCollection 2013.
6
Identification of BR102910 as a selective fibroblast activation protein (FAP) inhibitor.鉴定 BR102910 为一种选择性成纤维细胞激活蛋白(FAP)抑制剂。
Bioorg Med Chem Lett. 2021 Apr 1;37:127846. doi: 10.1016/j.bmcl.2021.127846. Epub 2021 Feb 9.
7
Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy.针对表达成纤维细胞激活蛋白的癌相关成纤维细胞作为一种新的化疗策略的背后原理。
Mol Cancer Ther. 2012 Feb;11(2):257-66. doi: 10.1158/1535-7163.MCT-11-0340.
8
Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold.具有(4-喹啉甲酰基)-甘氨酰-2-氰基吡咯烷骨架的成纤维细胞活化蛋白(FAP)选择性抑制剂
ACS Med Chem Lett. 2013 Mar 18;4(5):491-6. doi: 10.1021/ml300410d. eCollection 2013 May 9.
9
Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications.成纤维细胞激活蛋白的分子识别及其在诊断和治疗中的应用。
Biochim Biophys Acta Proteins Proteom. 2020 Jul;1868(7):140409. doi: 10.1016/j.bbapap.2020.140409. Epub 2020 Apr 6.
10
Selective Homogeneous Assay for Circulating Endopeptidase Fibroblast Activation Protein (FAP).选择性均相酶法检测循环内肽酶成纤维细胞激活蛋白(FAP)。
Sci Rep. 2017 Oct 2;7(1):12524. doi: 10.1038/s41598-017-12900-8.

引用本文的文献

1
Preclinical evaluation of [Ga]Ga-AAZTA-FAPI-46: a novel PET tracer for targeting fibroblast activation protein (FAP).[镓]Ga-AAZTA-FAPI-46的临床前评估:一种用于靶向成纤维细胞活化蛋白(FAP)的新型正电子发射断层显像(PET)示踪剂
EJNMMI Radiopharm Chem. 2025 Aug 5;10(1):51. doi: 10.1186/s41181-025-00375-2.
2
Macrocyclic Phage Display for Identification of Selective Protease Substrates.用于鉴定选择性蛋白酶底物的大环噬菌体展示技术
J Am Chem Soc. 2025 Jul 30;147(30):26307-26318. doi: 10.1021/jacs.5c04424. Epub 2025 Jul 18.
3
Macrocyclic phage display for identification of selective protease substrates.用于鉴定选择性蛋白酶底物的大环噬菌体展示
bioRxiv. 2025 Mar 15:2025.03.13.643185. doi: 10.1101/2025.03.13.643185.
4
Unveiling the Tumor Microenvironment Through Fibroblast Activation Protein Targeting in Diagnostic Nuclear Medicine: A Didactic Review on Biological Rationales and Key Imaging Agents.通过诊断核医学中靶向成纤维细胞活化蛋白揭示肿瘤微环境:关于生物学原理和关键显像剂的教学综述
Biology (Basel). 2024 Nov 24;13(12):967. doi: 10.3390/biology13120967.
5
Cosolvent Molecular Dynamics Applied to DPP4, DPP8 and DPP9: Reproduction of Important Binding Features and Use in Inhibitor Design.共溶剂分子动力学在 DPP4、DPP8 和 DPP9 中的应用:重现重要的结合特征并用于抑制剂设计。
J Chem Inf Model. 2024 Oct 14;64(19):7650-7665. doi: 10.1021/acs.jcim.4c01167. Epub 2024 Sep 27.
6
3BP-3940, a highly potent FAP-targeting peptide for theranostics - production, validation and first in human experience with Ga-68 and Lu-177.3BP-3940,一种用于诊疗的高效靶向成纤维细胞活化蛋白(FAP)的肽——生产、验证及首例使用镓-68和镥-177的人体试验经验
iScience. 2023 Nov 23;26(12):108541. doi: 10.1016/j.isci.2023.108541. eCollection 2023 Dec 15.
7
Establishment of FAP-overexpressing Cells for FAP-targeted Theranostics.建立 FAP 过表达细胞用于 FAP 靶向治疗学。
Curr Med Sci. 2023 Jun;43(3):623-630. doi: 10.1007/s11596-023-2740-7. Epub 2023 May 24.
8
Role and mechanism of fibroblast-activated protein-α expression on the surface of fibroblast-like synoviocytes in rheumatoid arthritis.成纤维细胞激活蛋白-α在类风湿关节炎成纤维样滑膜细胞表面表达的作用及机制。
Front Immunol. 2023 Mar 17;14:1135384. doi: 10.3389/fimmu.2023.1135384. eCollection 2023.
9
Novel Generation of FAP Inhibitor-Based Homodimers for Improved Application in Radiotheranostics.基于FAP抑制剂的新型同二聚体的生成,用于改进在放射治疗诊断中的应用。
Cancers (Basel). 2023 Mar 21;15(6):1889. doi: 10.3390/cancers15061889.
10
From Automated Synthesis to In Vivo Application in Multiple Types of Cancer-Clinical Results with [Ga]Ga-DATA.SA.FAPi.从自动合成到[镓]镓-DATA.SA.FAPi在多种癌症中的体内应用——临床结果
Pharmaceuticals (Basel). 2022 Aug 14;15(8):1000. doi: 10.3390/ph15081000.

本文引用的文献

1
The development and validation of a combined kinetic fluorometric activity assay for fibroblast activation protein alpha and prolyl oligopeptidase in plasma.开发并验证了一种用于血浆中成纤维细胞激活蛋白α和脯氨酰寡肽酶的联合动力学荧光活性测定法。
Clin Chim Acta. 2019 Aug;495:154-160. doi: 10.1016/j.cca.2019.04.063. Epub 2019 Apr 11.
2
Fibroblast activation protein in liver fibrosis.肝纤维化中的成纤维细胞激活蛋白。
Front Biosci (Landmark Ed). 2019 Jan 1;24(1):1-17. doi: 10.2741/4706.
3
Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers.镓-FAPI PET/CT:不同癌症患者中两种含 DOTA 的 FAP 靶向剂的生物分布和初步剂量估算。
J Nucl Med. 2019 Mar;60(3):386-392. doi: 10.2967/jnumed.118.215913. Epub 2018 Aug 2.
4
Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics.成纤维细胞激活蛋白在癌症中的促瘤作用:回归基础。
Oncogene. 2018 Aug;37(32):4343-4357. doi: 10.1038/s41388-018-0275-3. Epub 2018 May 3.
5
A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts.一种针对肿瘤相关成纤维细胞的肿瘤成像方法。
J Nucl Med. 2018 Sep;59(9):1423-1429. doi: 10.2967/jnumed.118.210435. Epub 2018 Apr 6.
6
Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein.基于喹啉的治疗性配体的开发用于成纤维细胞激活蛋白的靶向治疗。
J Nucl Med. 2018 Sep;59(9):1415-1422. doi: 10.2967/jnumed.118.210443. Epub 2018 Apr 6.
7
Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory Pain.口服可溶型环氧化物水解酶/磷酸二酯酶 4 双重抑制剂治疗炎症性疼痛。
J Med Chem. 2018 Apr 26;61(8):3541-3550. doi: 10.1021/acs.jmedchem.7b01804. Epub 2018 Apr 10.
8
Imaging fibroblast activation protein to monitor therapeutic effects of neutralizing interleukin-22 in collagen-induced arthritis.利用成纤维细胞活化蛋白成像来监测中和白细胞介素-22 在胶原诱导性关节炎中的治疗效果。
Rheumatology (Oxford). 2018 Apr 1;57(4):737-747. doi: 10.1093/rheumatology/kex456.
9
Selective Homogeneous Assay for Circulating Endopeptidase Fibroblast Activation Protein (FAP).选择性均相酶法检测循环内肽酶成纤维细胞激活蛋白(FAP)。
Sci Rep. 2017 Oct 2;7(1):12524. doi: 10.1038/s41598-017-12900-8.
10
Inhibitor-Decorated Polymer Conjugates Targeting Fibroblast Activation Protein.靶向成纤维细胞活化蛋白的抑制剂修饰聚合物偶联物
J Med Chem. 2017 Oct 26;60(20):8385-8393. doi: 10.1021/acs.jmedchem.7b00767. Epub 2017 Oct 16.

新型小分子衍生的成纤维细胞活化蛋白(FAP)高选择性底物

Novel Small Molecule-Derived, Highly Selective Substrates for Fibroblast Activation Protein (FAP).

作者信息

De Decker An, Vliegen Gwendolyn, Van Rompaey Dries, Peeraer Anke, Bracke An, Verckist Line, Jansen Koen, Geiss-Friedlander Ruth, Augustyns Koen, De Winter Hans, De Meester Ingrid, Lambeir Anne-Marie, Van der Veken Pieter

机构信息

Laboratory of Medicinal Chemistry (UAMC), Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk (Antwerp), Belgium.

Laboratory of Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk (Antwerp), Belgium.

出版信息

ACS Med Chem Lett. 2019 Jul 9;10(8):1173-1179. doi: 10.1021/acsmedchemlett.9b00191. eCollection 2019 Aug 8.

DOI:10.1021/acsmedchemlett.9b00191
PMID:31413802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6691567/
Abstract

Fibroblast activation protein (FAP) is a proline-selective serine protease. It is hardly expressed in healthy adult tissue but upregulated in tissue remodeling sites associated with several diseases including epithelial cancer types, atherosclerosis, arthritis and fibrosis. Ongoing research aims at clinical implementation of FAP as a biomarker for these diseases. Several immunochemical methods that quantify FAP expression have been reported. An alternative/complementary approach focuses on quantification of FAP's enzymatic activity. Developing an activity-based assay for FAP has nonetheless proven challenging because of selectivity issues with respect to prolyl oligopeptidase (PREP). Here, we present substrate-type FAP probes that are structurally derived from a FAP-inhibitor (UAMC1110) that we published earlier. Both cleavage efficiency and FAP-selectivity of the best compounds in the series equal or surpass the most advanced peptide-based FAP substrates reported to date. Finally, proof-of-concept is provided that 4-aminonaphthol containing probes can spatially localize FAP activity in biological samples.

摘要

成纤维细胞活化蛋白(FAP)是一种脯氨酸选择性丝氨酸蛋白酶。它在健康成人组织中几乎不表达,但在与多种疾病相关的组织重塑部位上调,这些疾病包括上皮癌类型、动脉粥样硬化、关节炎和纤维化。正在进行的研究旨在将FAP作为这些疾病的生物标志物用于临床。已经报道了几种定量FAP表达的免疫化学方法。一种替代/补充方法侧重于定量FAP的酶活性。然而,由于脯氨酰寡肽酶(PREP)的选择性问题,开发一种基于活性的FAP检测方法已被证明具有挑战性。在这里,我们展示了底物型FAP探针,其结构源自我们之前发表的一种FAP抑制剂(UAMC1110)。该系列中最佳化合物的切割效率和FAP选择性均等于或超过了迄今为止报道的最先进的基于肽的FAP底物。最后,提供了概念验证,即含有4-氨基萘酚的探针可以在生物样品中对FAP活性进行空间定位。